JP2003534805A5 - - Google Patents

Download PDF

Info

Publication number
JP2003534805A5
JP2003534805A5 JP2002500739A JP2002500739A JP2003534805A5 JP 2003534805 A5 JP2003534805 A5 JP 2003534805A5 JP 2002500739 A JP2002500739 A JP 2002500739A JP 2002500739 A JP2002500739 A JP 2002500739A JP 2003534805 A5 JP2003534805 A5 JP 2003534805A5
Authority
JP
Japan
Prior art keywords
leu
gly
thr
ser
adenovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002500739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003534805A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2001/000798 external-priority patent/WO2001092547A2/en
Publication of JP2003534805A publication Critical patent/JP2003534805A/ja
Publication of JP2003534805A5 publication Critical patent/JP2003534805A5/ja
Pending legal-status Critical Current

Links

JP2002500739A 2000-05-31 2001-05-31 変化した親和性を有する改変ウシアデノウイルス Pending JP2003534805A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20867800P 2000-05-31 2000-05-31
US60/208,678 2000-05-31
PCT/CA2001/000798 WO2001092547A2 (en) 2000-05-31 2001-05-31 Modified bovine adenovirus having altered tropism

Publications (2)

Publication Number Publication Date
JP2003534805A JP2003534805A (ja) 2003-11-25
JP2003534805A5 true JP2003534805A5 (enExample) 2008-06-05

Family

ID=22775551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002500739A Pending JP2003534805A (ja) 2000-05-31 2001-05-31 変化した親和性を有する改変ウシアデノウイルス

Country Status (6)

Country Link
US (1) US6849446B2 (enExample)
EP (1) EP1285079A2 (enExample)
JP (1) JP2003534805A (enExample)
AU (2) AU6368901A (enExample)
CA (1) CA2410665C (enExample)
WO (1) WO2001092547A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820868A (en) 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US20030220284A1 (en) * 2002-02-22 2003-11-27 Patricia Yotnda Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
FR2842823A1 (fr) * 2002-07-25 2004-01-30 Inst Nat Sante Rech Med Adenovirus modifies pour le ciblage des lymphocytes b
WO2004108755A2 (en) * 2003-06-10 2004-12-16 University Of Saskatchewan Chimeric adenovirus capsid proteins
AU2005309485A1 (en) * 2004-11-24 2006-06-01 Nanovector Limited Viral vectors
CA2658805A1 (en) 2006-07-28 2008-01-31 Commonwealth Scientific And Industrial Research Organisation Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
KR100812636B1 (ko) 2006-10-24 2008-03-13 주식회사 단바이오텍 항원 결정기를 포함하는 재조합 개 아데노바이러스 섬유단백질 및 이에 대한 항체
US8865182B2 (en) * 2009-07-31 2014-10-21 Paxvax, Inc. Adenoviral-based vectors
CA2903582C (en) 2013-03-14 2021-06-08 Salk Institute For Biological Studies Oncolytic adenovirus compositions
JP7015551B2 (ja) 2016-02-23 2022-02-15 ソーク インスティテュート フォー バイオロジカル スタディーズ ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
WO2017147265A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
CA3045892A1 (en) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
CA3095660A1 (en) * 2018-02-15 2019-08-22 Tomas Bjorklund Modified viral capsids
BR112020019942A2 (pt) 2018-04-09 2021-01-26 Salk Institute For Biological Studies composições de adenovírus oncolítico com propriedades de replicação aprimoradas

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
ZA858044B (en) 1984-11-01 1987-05-27 American Home Prod Oral vaccines
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US5151267A (en) 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
FR2642767B1 (fr) 1989-01-19 1993-10-01 Transgene Sa Vecteurs d'expression de proteines heterologues dans les cellules eucaryotes, lignees cellulaires obtenues et procede pour leur preparation
EP0389286B1 (en) 1989-03-24 1996-07-10 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
GB9001766D0 (en) 1990-01-25 1990-03-28 Univ Court Of The University O Vaccines
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US5559099A (en) 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US6127525A (en) 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
AUPN477695A0 (en) * 1995-08-14 1995-09-07 Commonwealth Scientific And Industrial Research Organisation Gene therapy
IL124654A0 (en) * 1995-11-28 1998-12-06 Genvec Inc Vectors and method for gene transfer to cells
US5871727A (en) 1995-12-08 1999-02-16 Uab Research Foundation Targeted adenovirus vectors
IL128958A0 (en) * 1996-09-25 2000-02-17 Novartis Ag And The Scripps Re Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
US5877011A (en) * 1996-11-20 1999-03-02 Genzyme Corporation Chimeric adenoviral vectors
FR2761689B1 (fr) * 1997-04-02 1999-06-25 Transgene Sa Fibre adenovirale modifiee et adenovirus cibles
JP4812914B2 (ja) * 1997-06-23 2011-11-09 ユニバーシティ オブ サスカチュワン ウシアデノウイルスタイプ3ゲノム
EP1044274A2 (en) * 1998-01-16 2000-10-18 Genzyme Corporation Adenoviral vectors with modified capsid proteins
CN1304316A (zh) 1998-02-06 2001-07-18 亚拉巴马大学伯明翰分校研究基金会 在纤维结的hi环中含有异源肽表位的腺病毒载体
AU751542B2 (en) 1998-02-17 2002-08-22 Uab Research Foundation, The Modified adenovirus containing a fiber replacement protein
US5922576A (en) 1998-02-27 1999-07-13 The John Hopkins University Simplified system for generating recombinant adenoviruses
US20030017138A1 (en) * 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
CA2342396A1 (en) * 1998-09-11 2000-03-23 Genvec, Inc. Alternatively targeted adenovirus
AU780822B2 (en) * 1998-11-02 2005-04-21 University Of Saskatchewan Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
IL133032A (en) 1998-11-20 2007-06-03 Introgene Bv Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells
EP1816204B1 (en) 1999-05-17 2010-10-20 Crucell Holland B.V. Recombinant Adenovirus of the Ad26 serotype
JP2003531568A (ja) 1999-07-06 2003-10-28 ゴット−エー−ジェーン・エービー 組換え型アデノウイルス
CA2384827A1 (en) 1999-09-24 2001-03-29 The Uab Research Foundation Capsid-modified recombinant adenovirus and methods of use

Similar Documents

Publication Publication Date Title
ES2246533T3 (es) Fibra adenovirica modificada y adenovirus dianas.
EP1307573B1 (en) Adenoviral vectors for the transduction of chondrocytes
US6849446B2 (en) Modified bovine adenovirus having altered tropism
JP2003534805A5 (enExample)
AU2001263689A1 (en) Modified bovine adenovirus having altered tropism
JP2003508057A (ja) 改変アデノウイルスファイバーおよび用途
US6319716B1 (en) Bovine adenovirus type 3 genome and vector systems derived therefrom
US6451319B1 (en) Recombinant and mutant adenoviruses
AU780822B2 (en) Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
CA2527721C (en) Chimeric adenovirus capsid proteins
AU2001280006B2 (en) Adenovirus vectors comprising introns
AU2001280006A1 (en) Adenovirus vectors comprising introns
US7264818B2 (en) BAV packaging regions and E1 transcriptional control regions
US20220154209A1 (en) Pv-deleted bovine adenovirus
CA2365911A1 (en) Recombinant and mutant adenoviruses derived of bovine adenovirus type 1